10 September 2026

Cancer Immunotherapy PBS

PBS widens pembrolizumab access

27 August 2026

Diabetes PBS TGA

NMSC: common, deadly, preventable

27 August 2026

Diabetes PBS TGA

Pilots, flight attendants have increased cancer-related mortality

27 August 2026

oncology PBAC PBS Pharmaceuticals

PBAC nod for cancer drugs

13 August 2026

PBS Pharmaceuticals

GBMA targets medicine shortages

13 August 2026

Immunotherapy PBS

Chemo-free immunotherapy combo for follicular lymphoma gets PBS listing

16 July 2026

Breast cancer PBS Pharmaceuticals

AstraZeneca announces new access program for cancer implant

4 June 2026

Leukaemia PBS Pharmaceuticals

PBS listing opens access to breakthrough therapy

7 May 2026

PBS TGA

New cancer drug subsidies and registrations

23 April 2026

PBS Pharmaceuticals

Aussie-made hereditary angioedema therapy gains PBS listing

9 April 2026

Cancer PBS

PBS expands pembrolizumab access for three cancers

12 March 2026

PBS Pharmaceuticals

Consolidated listing for combination immune checkpoint inhibitors

4 December 2025

PBS Pharmaceuticals

Green light for first targeted therapy for relapsed myeloma

3 December 2025

PBS Pharmaceuticals

Frontline myeloma therapy lands on the PBS

6 November 2025

PBS Pharmaceuticals

New PBS listing for front-line lymphoma therapy

23 October 2025

Cancer Immunotherapy PBAC PBS

Immunotherapy treatment recommended for broad PBS listing

3 July 2025

PBAC Pharmaceuticals

Liver, endometrial and lung cancer drugs discussed at PBAC

5 June 2025

Lung cancer PBS Pharmaceuticals

Targeted lung cancer therapy added to PBS

24 April 2025

Chemotherapy Leukaemia

Move over, chemoimmunotherapy

24 April 2025

Cancer PBS

Aussie myelofibrosis drug added to PBS